MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
172 hedge funds and large institutions have $4.48B invested in Mirati Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 65 increasing their positions, 40 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
172
Holders Change
+13
Holders Change %
+8.18%
% of All Funds
3.74%
Holding in Top 10
13
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+85.71%
% of All Funds
0.28%
New
46
Increased
65
Reduced
40
Closed
30
Calls
$214M
Puts
$108M
Net Calls
+$106M
Net Calls Change
+$72.4M
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$179M |
| 2 |
Sands Capital Management
Arlington,
Virginia
|
+$142M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$82.7M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$79.3M |
| 5 |
Renaissance Technologies
New York
|
+$41.1M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$173M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$41.4M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$36.8M |
| 4 |
State Street
Boston,
Massachusetts
|
-$27.8M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$26.1M |
